image

The best stocks to buy since 1993

Latest issue now available

Synergy Health - Gain to date

November 2010

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • SYR
  • Price:
  • 784p
Synergy's pre-close update said H1 trading was in line and that margins have continued to improve further. Trading patterns in Q2 were similar to Q1 with revenue growth on the sterilisation and decontamination side offset by flat sales on the hospital linen business. The bid pipeline has improved with a large contract win for a decontamination unit in the UK bolstering the order book by £60m to £860m. Meanwhile, new discussions for decontamination services continue in China.  Net debt has now reduced to £118m. So in a word, excellent.KBC forecasts eps of 51.5p this year to 31 March with 55.4p next year. Tipped at 499p in July ‘09, take a part profit if you want. Hold th ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER

SUBSCRIBE TODAY AND SAVE £40 WITH OFFER CODE 40OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe